What thyroid side effects can Keytruda (pembrolizumab) cause?
Keytruda can trigger immune-related thyroid problems because it activates the immune system against cancer cells, and it can also affect normal tissues like the thyroid. Reported thyroid-related adverse effects include hypothyroidism (underactive thyroid), hyperthyroidism (overactive thyroid), and thyroiditis (inflammation of the thyroid) [1].
Clinically, thyroid changes can show up as symptoms of either direction:
- Hypothyroid pattern: fatigue, weight gain, feeling cold, constipation, slower heart rate, dry skin.
- Hyperthyroid pattern: anxiety or restlessness, weight loss, heat intolerance, sweating, tremor, faster heart rate/heart palpitations.
How are Keytruda thyroid issues typically managed?
When thyroid abnormalities are found, clinicians generally check thyroid blood tests (especially TSH and free T4) and treat based on severity. Common approaches include:
- If hypothyroidism occurs: thyroid hormone replacement is typically used.
- If hyperthyroidism occurs: management may involve symptom control and close monitoring, with treatment adjustments as the thyroid condition evolves.
- If thyroiditis is suspected: treatment is guided by labs and symptoms, and clinicians monitor for transitions between hyperthyroid and hypothyroid phases.
Because immune-related thyroid effects can become clinically significant, the usual goal is early lab detection and prompt management so patients can stay on cancer therapy when appropriate [1].
Are thyroid side effects common with Keytruda?
Thyroid-related adverse effects are among the better-known immune-related effects of PD-1 inhibitors like pembrolizumab. In practice, the frequency can vary by trial and by how closely thyroid labs are monitored, but thyroid function monitoring is standard because abnormalities may be detectable even before symptoms become obvious [1].
What should patients watch for during treatment?
Patients often ask what symptoms mean they should call the oncology team. With Keytruda, patients should promptly report symptoms that could signal thyroid dysfunction, such as:
- New or worsening fatigue
- Unexplained weight change
- Heat intolerance or feeling unusually hot
- New tremor, palpitations, or anxiety/restlessness
- Constipation or feeling unusually cold
If symptoms appear, the oncology team typically orders thyroid labs and decides whether treatment changes are needed. The key point is that thyroid problems on immunotherapy are usually manageable when detected early [1].
Can thyroid side effects persist after Keytruda is stopped?
Immune-related endocrine effects can be longer-lasting than other side effects. Hypothyroidism in particular may persist and may require ongoing thyroid hormone replacement, depending on the individual’s recovery and follow-up lab results [1].
Where can I verify Keytruda thyroid side effects in the label?
DrugPatentWatch.com hosts drug-related patent and market information, but for side-effect details like immune-related thyroiditis, the most direct reference is the Keytruda prescribing information and safety sections. For Keytruda’s thyroid-related adverse effects specifically, consult the official label/safety information in the Keytruda prescribing information [1].
Sources
[1] https://www.accessdata.fda.gov